Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 4 of 4 entries
View as:

Cetuximab+Zimberelimab in Combination With Cisplatin and Nab-paclitaxel in Resctable Head and Neck Squamous Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT06107114 Org: User:
Start: 12/01/23 End: 12/01/24 Due: 12/01/25

Neoadjuvant Cadonilimab in Combination With Cisplatin and Nab-paclitaxel in Resectable Head and Neck Squamous Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT06023875 Org: User:
Start: 07/19/23 End: 12/31/24 Due: 12/31/25

CO2 Laser and Open Surgery for T1N0 Glottic SCC With Anterior Commissure Involved

Phase: N/A Priority: Normal
NCT ID: NCT02303457 Org: User:
Start: 07/31/14 End: 07/31/24 Due: 07/31/25

A Prospective, Single-arm Phase II Clinical Trial of Tislelizumab Combined With Platinum Doublet Neoadjuvant Therapy to Improve Mandibular Preservation in Resectable Locally Advanced Oral Squamous Cell Carcinoma.

Phase: N/A Priority: Normal
NCT ID: NCT06130007 Org: User:
Start: 11/25/23 End: 10/25/24 Due: 10/25/25